Eric Thomas Schmidt's Net Worth
$18.2 Million
Who is Eric Thomas Schmidt?
Eric Thomas Schmidt has an estimated net worth of $18.2 Million. This is based on reported shares across multiple companies, which include Allogene Therapeutics, Inc., Revolution Medicines, Inc., and RELMADA THERAPEUTICS, INC..
SEC CIK
Eric Thomas Schmidt's CIK is 0001754403
Past Insider Trading and Trends
2021 was Eric Thomas Schmidt's most active year for acquiring shares with 7 total transactions. Eric Thomas Schmidt's most active month to acquire stocks was the month of February. 2020 was Eric Thomas Schmidt's most active year for disposing of shares, totalling 15 transactions. Eric Thomas Schmidt's most active month to dispose stocks was the month of December. 2021 saw Eric Thomas Schmidt paying a total of $271,423.34 for 307,169 shares, this is the most they've acquired in one year. In 2020 Eric Thomas Schmidt cashed out on 332,605 shares for a total of $8,045,112.87, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Allogene Therapeutics, Inc. (ALLO) Snapshot price: $4.13
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +183.38% | 558.09K |
—
|
—
| 862.44K |
Mar 22
| |||
Form 4
| -10.55% | -35.88K |
$5.47 | -$196,258.13 | 304.35K |
Mar 14
| |||
Form 4
| +236.07% | 237.36K |
—
|
—
| 337.9K |
Mar 23
| |||
Form 4
| -10.24% | -11.47K |
$7.63 | -$87,550.91 | 100.55K |
Mar 15
| |||
Form 4
| +15.50% | 14.9K |
$18.22 | $271,423.34 | 110.99K |
May 24
| |||
Form 4
| +34.91% | 24.87K |
—
|
—
| 96.1K |
Mar 26
| |||
Form 4
| -10.16% | -8.05K |
$38.23 | -$307,888.74 | 71.23K |
Mar 15
| |||
Form 4
| -2.54% | -30.00K |
$31.52 | -$945,469.15 | 1.15M |
Scheduled
|
Jan 14 - Jan 15
| ||
Form 4
| -1.25% | -15.00K |
$32.88 | -$493,146.40 | 1.18M |
Scheduled
|
Nov 16
| ||
Form 4
| -1.24% | -15.00K |
$40.49 | -$607,392.37 | 1.2M |
Scheduled
|
Oct 15
| ||
Form 4
| -1.22% | -15.00K |
$35.30 | -$529,544.75 | 1.21M |
Scheduled
|
Sep 21
| ||
Form 4
| +64.29% | 30.8K |
—
|
—
| 78.71K |
Mar 18
| |||
Form 4
| -5.42% | -5.45K |
$19.98 | -$107,507.85 | 95.16K |
Mar 16
| |||
Form 4
| -16.19% | -237.16K |
$25.30 | -$6,000,021.50 | 1.23M |
Feb 20
| |||
Form 4
|
∞
| 49.4K |
—
|
—
| 49.4K |
Mar 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Revolution Medicines, Inc. (RVMD) Snapshot price: $29.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +32.40% | 5.2K |
—
|
—
| 21.25K |
Jun 8
| |||
Form 4
| +47.92% | 5.2K |
—
|
—
| 16.05K |
Jun 16
| |||
Form 4
| +50.00% | 3.62K |
—
|
—
| 10.85K |
Jun 22
| |||
Form 4
|
∞
| 7.23K |
—
|
—
| 7.23K |
Jun 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RELMADA THERAPEUTICS, INC. (RLMD) Snapshot price: $5.15
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
| +81.82% | 45K |
$6.83 | $307,500.00 | 100K |
Apr 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||